Latest Breaking News On - Armata pharmaceuticals - Page 1 : vimarsana.com

Armata Pharmaceuticals, Inc (NYSEAMERICAN:ARMP) Short Interest Update

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 800 shares, a decline of 92.5% from the April 30th total of 10,700 shares. Approximately 0.0% of the shares of the stock are short sold. Based […]

Armata pharmaceuticals stock performanceArmata pharmaceuticals incArmata pharmaceuticalsInstitutional investors weigh in on armata pharmaceuticalsSecurities exchange commissionNews ratings for armata pharmaceuticals dailySeacrest wealth managementGet free reportCrest wealth managementFree reportArmata pharmaceuticals daily

Armata Pharmaceuticals, Inc (NYSEAMERICAN:ARMP) Sees Significant Drop in Short Interest

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 800 shares, a decrease of 92.5% from the April 30th total of 10,700 shares. Based on an average trading volume of 16,600 shares, […]

Armata pharmaceuticals company profileSeacrest wealth managementArmata pharmaceuticals incNews ratings for armata pharmaceuticals dailyArmata pharmaceuticalsHedge funds weigh in on armata pharmaceuticalsArmata pharmaceuticals stock downGet free reportCrest wealth managementFree reportPharmaceuticals stock downArmata pharmaceuticals daily

Anticipation mounts as Insmed s bronchiectasis therapy nears phase 3 completion

Anticipation mounts as Insmed s bronchiectasis therapy nears phase 3 completion
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.

Filippos maniatisBoehringer ingelheimArmata pharmaceuticals

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Posts Quarterly Earnings Results, Misses Expectations By $0 41 EPS

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Posts Quarterly Earnings Results, Misses Expectations By $0 41 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Armata pharmaceuticals stock performanceSecurities exchange commissionEarnings history for armata pharmaceuticalsArmata pharmaceuticalsSeacrest wealth managementNews ratings for armata pharmaceuticals dailyArmata pharmaceuticals incGet free reportCrest wealth managementFree reportArmata pharmaceuticals daily

ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Armata pharmaceuticalsArmata pharmaceuticals missesMarket newsStock adviceMisses revenue